Position in BCRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$11,204,690
+$3,580,122 QoQ
Shares Held
1,120,469
+39.9% QoQ
Ownership
0.438%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#48
of 316 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $670,557,120 across 30 Drug Manufacturers - Specialty & Generic names. BCRX ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
923,125 | $155,583,487 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
249,056 | $134,946,012 | |
| 3 | ALKS |
Alkermes plc.
|
2,421,016 | $126,861,238 | |
| 4 | ZTS |
Zoetis Inc.
|
1,435,652 | $103,165,952 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,114,912 | $33,902,039 | |
| 6 | LQDA |
Liquidia Corp
|
301,432 | $24,033,173 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
1,120,469 | $11,204,690 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
614,206 | $10,631,905 |
All Filings in BCRX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,204,690 | 1,120,469 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $7,624,568 | 800,900 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,924,695 | 374,961 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,578,551 | 734,987 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,518,131 | 727,470 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,641,115 | 485,482 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,250,416 | 565,215 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,510,341 | 593,466 | Shares | Sole | 2024-11-13 | |
| 2024-03-31 | $718,245 | 141,387 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $962,736 | 160,724 | Shares | Sole | 2024-02-13 | |
| 2023-06-30 | $1,244,411 | 176,763 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,360,779 | 163,163 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,337,718 | 203,634 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,575,856 | 125,068 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,013,723 | 284,851 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,845,776 | 175,017 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,234,651 | 305,751 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $3,541,429 | 246,446 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,483,429 | 346,833 | Shares | Sole | 2021-10-12 | |
| No filing history on record for this holder in this stock. | ||||||